Elevance Health Inc.
NYSE:ELVMedical - Healthcare Plans
Healthcare
$394.48 -0.88%
-$3.45 today
- Market cap
- $85.23B
- Beta
- 0.68
- P/E (TTM)
- 16.3
- EPS (TTM)
- $23.78
- Dividend yield
- 1.77%
52W Low $273.71High $426.98
Volume 2.04M
Average 1.68M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$4.29B
FY 2025 · Annual
-26.1% YoYInvesting Cash Flow
-$1.34B
FY 2025 · Annual
Financing Cash Flow
-$1.74B
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 6.1B | 6.02B | 5.99B | 5.97B | 5.66B |
| Depreciation & Amortization | 1.3B | 1.68B | 1.75B | 1.39B | 1.55B |
| Deferred Income Tax | 173M | (76M) | (602M) | (374M) | (279M) |
| Stock-Based Compensation | 255M | 264M | 289M | 191M | 276M |
| Change in Working Capital | 784M | 253M | (535M) | (1.72B) | (3.28B) |
| Accounts Receivables | (2.14B) | (2.51B) | (1.76B) | (683M) | (2.53B) |
| Inventory | 2.14B | 2.51B | 0 | 0 | 0 |
| Accounts Payables | 719M | 252M | 1.64B | (272M) | (720M) |
| Other Working Capital | 65M | 1M | (413M) | (764M) | (31M) |
| Other Non-Cash Items | (245M) | 264M | 1.18B | 346M | 363M |
| Operating Cash Flow | 8.36B | 8.4B | 8.06B | 5.81B | 4.29B |
| Capital Expenditures | (1.09B) | (1.15B) | (1.3B) | (1.26B) | (1.12B) |
| Acquisitions (Net) | (3.48B) | (649M) | (1.55B) | (4.45B) | 88M |
| Purchases of Investments | (18.67B) | (24.95B) | (16.24B) | (17.99B) | (15.03B) |
| Sales of Investments | 14.61B | 22.61B | 13.54B | 18.57B | 15.1B |
| Other Investing Activities | (1.02B) | (421M) | (24M) | (51M) | (385M) |
| Investing Cash Flow | (9.64B) | (4.56B) | (5.57B) | (5.17B) | (1.34B) |
| Debt Repayment | 2.34B | 1.8B | 739M | 5.56B | 2.33B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (1.9B) | (2.32B) | (2.68B) | (2.9B) | (2.61B) |
| Dividends Paid | (1.1B) | (1.23B) | (1.4B) | (1.51B) | (1.53B) |
| Other Financing Activities | 1.08B | 432M | (17M) | 39M | 69M |
| Financing Cash Flow | 423M | (1.32B) | (3.35B) | 1.19B | (1.74B) |
| Effect of Forex Changes | (10M) | (14M) | (1M) | (72M) | (5M) |
| Net Change in Cash | (861M) | 2.51B | (861M) | 1.76B | 1.2B |
| Free Cash Flow | 7.28B | 7.25B | 6.77B | 4.55B | 3.17B |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$5.7B
+ D&A$1.5B
+ Stock-Based Comp$276.0M
- Deferred Tax-$279.0M
- Working Capital-$3.3B
+ Other Non-Cash$363.0M
= Operating Cash Flow$4.3B
- Capex-$1.1B
= Free Cash Flow$3.2B
Analysis
FY2025 free cash flow is $3.2B. FCF conversion is 56.1% of net income. Operating cash flow was $4.3B, with capex of -$1.1B. The largest bridge item is Working Capital at -$3.3B.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| S-3ASR | S-3ASR filing | Oct 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 23, 2026 | |
| 8-K | Current report | Oct 21, 2026 |
Does ELV generate free cash flow?
Elevance Health Inc. (ELV) generated $3.17B of free cash flow in fiscal 2025.
How much operating cash flow does ELV produce?
Operating cash flow was $4.29B, before capital expenditures of $1.12B.
Continue the stock analysis
Jump to another research area for this company.